Skip to content

27+ 8065751697Recalls & reported problems

Alcon Laboratories, Inc. · 27+ Valved Entry System (3-CT) · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380657516971), received between Feb 27, 2023 and Feb 27, 2023 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Fluid/Blood Leak2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 27, 2023Fluid/Blood Leak; Fluid/Blood Leak

    A NON HEALTHCARE PROFESSIONAL REPORTED ON BEHALF OF THE PHYSICIAN THAT THE TROCAR LEAKED TERRIBLY FROM PAST COUPLE OF WEEKS AND WAS NOT SURE IF THERE WERE ANY OTHER COMPLAINTS REPORTED. IT WAS NOT REPORTED IF THERE WAS ANY PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16449754 ↗
  • MalfunctionFeb 27, 2023Fluid/Blood Leak; Fluid/Blood Leak

    A NON HEALTHCARE PROFESSIONAL REPORTED ON BEHALF OF THE PHYSICIAN THAT THE TROCAR LEAKED TERRIBLY FROM PAST COUPLE OF WEEKS AND WAS NOT SURE IF THERE WERE ANY OTHER COMPLAINTS REPORTED. IT WAS NOT REPORTED IF THERE WAS ANY PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16445506 ↗

Other Unit, phacofragmentation devices

All Unit, phacofragmentation devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page